The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Residents demonstrate due to water shortage in Apizaquito, Tlaxcala Jun 30, 2021
- Ontario health officials tell doctors to look at patients in person rather than realistically Oct 13, 2021
- Doctor Who leaked filming footage, first look at David Tennant and Catherine Tate May 24, 2022
- Boxing Oscar De La Hoya’s return to the ring was canceled due to a coronary infection that led to hospitalization: “ Sep 4, 2021
- Effects of stress and anxiety on skin health May 30, 2022
- 82-year-old man’s wrong leg is mistakenly amputated May 29, 2021
- Military exercise of unprecedented scale in France in 2023 Nov 17, 2022